$MAIA Income Statement | Understand Stock

$MAIA

$1.17 +$0.06 (5.41%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Operating expenses:
Research and development expenses
General and administrative expenses
Ratchet share expense
Total operating expenses

Loss from operations
Other income (expense):
Interest expense
Interest income
Australian research and development incentives
Grant income
Loss on fair value of warrants over proceeds
Other income (expense) net:
Deemed dividend on warrant modification
Net loss attributable to MAIA Biotechnology, Inc. shareholders
Net loss
Net loss per share - basic
Net loss per share - diluted
Weighted average common shares outstanding - basic
Weighted average common shares outstanding - diluted

Comments